Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
9.46
-1.66 (-14.93%)
At close: Mar 18, 2026, 4:00 PM EDT
9.47
+0.01 (0.14%)
After-hours: Mar 18, 2026, 7:57 PM EDT
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $317.65 million as of March 18, 2026. Its market cap has increased by 612.81% in one year.
Market Cap
317.65M
Enterprise Value
302.47M
1-Year Change
612.81%
Ranking
Category
Stock Price
$9.46
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $317.65M, an increase of 383.16%. That is a compound annual growth rate of 44.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 585.97M | 112.62% |
| Dec 31, 2025 | 275.60M | 355.41% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Larimar Therapeutics | 376.60M |
| Absci | 375.93M |
| Enanta Pharmaceuticals | 374.64M |
| DiaMedica Therapeutics | 373.92M |
| PepGen | 369.77M |
| Opus Genetics | 369.26M |
| LENZ Therapeutics | 367.34M |
| Candel Therapeutics | 365.50M |